Xtx Topco LTD Ngm Biopharmaceuticals Inc Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.17 - $1.92 $3,456 - $5,671	-2,954 Reduced 10.19%	26,022 $41,000
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.31 $3,983 - $8,697	-6,639 Reduced 18.64%	28,976 $24,000
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $8,221 - $26,387	-7,830 Reduced 18.02%	35,615 $38,000
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $44,083 - $81,843	-18,067 Reduced 29.37%	43,445 $112,000
Q1 2023 May 12, 2023	BUY	$3.72 - $5.4 $228,824 - $332,164	61,512 New	61,512 $250,000
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $365,761 - $604,992	34,571 New	34,571 $443,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.